Thiogenesis Therapeutics, Corp. — Investor Relations & Filings
Thiogenesis Therapeutics, Corp. is a clinical-stage biotechnology company specializing in the development of New Chemical Entities (NCEs), specifically novel thiol-based prodrugs. These next-generation sulfur-containing therapeutics are designed to restore redox balance and mitigate inflammation, key drivers in inherited and acquired mitochondrial diseases. The company's lead candidate, TTI-0102, is a novel cysteamine prodrug engineered to overcome the limitations of legacy thiol therapies, offering enhanced tolerability, bioavailability, and improved dosing profiles. TTI-0102 is currently being evaluated for unmet pediatric medical needs, including nephropathic cystinosis (with a pivotal Phase 3 trial planned following an expected 2026 IND filing), MELAS (in Phase 2), and other conditions such as Leigh syndrome spectrum.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2026-05-11 | English | |
| ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF | 2026-04-30 | English | |
| 52-109FV1 - Certification of annual filings - CEO (E).pdf | 2026-04-30 | English | |
| Annual MD&A - English.pdf | 2026-04-30 | English | |
| News release - English.pdf | 2026-04-16 | English | |
| News release - English.pdf | 2026-04-16 | English |
Browse filings by year
8 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cenra Inc.
Diversified healthcare enterprise providing R&D, manufactur…
|
3716 | TW | Manufacturing |
|
Centessa Pharmaceuticals plc
Clinical-stage pharmaceutical company developing medicines …
|
CNTA | GB | Manufacturing |
|
Century Therapeutics, Inc.
Develops iPSC-derived allogeneic cell therapies for cancer …
|
IPSC | US | Manufacturing |
|
Cereno Scientific AB
Clinical-stage biotech developing drugs for rare cardiovasc…
|
CRNO | SE | Manufacturing |
|
CERO THERAPEUTICS HOLDINGS, INC.
Immunotherapy company developing engineered T cell therapeu…
|
CERO | US | Manufacturing |
|
CERUS CORP
Develops pathogen inactivation technology to reduce transfu…
|
CERS | US | Manufacturing |
|
Cessatech A/S
A biotech company developing medicines for children's acute…
|
CESSA | DK | Manufacturing |
|
CF PharmTech
Develops and manufactures inhalation drugs and delivery sys…
|
2652 | CN | Manufacturing |
|
CF PharmTech, Inc.
Specialty pharmaceutical company developing complex inhalat…
|
2652 | HK | Manufacturing |
|
CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomic…
|
083790 | KR | Manufacturing |
Thiogenesis Therapeutics, Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47770/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47770 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47770 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47770 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47770}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Thiogenesis Therapeutics, Corp. (id: 47770)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.